130 related articles for article (PubMed ID: 31260910)
1. Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis.
Hu YJ; Zhang LF; Ding C; Chen D; Chen J
Clin Neurol Neurosurg; 2019 Aug; 183():105401. PubMed ID: 31260910
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis.
Hu YJ; Chen D; Zhang LF; Chen J
World Neurosurg; 2019 Jul; 127():176-185. PubMed ID: 30959254
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
5. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
[TBL] [Abstract][Full Text] [Related]
8. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.
Steinmann D; Maertens B; Janssen S; Werner M; Frühauf J; Nakamura M; Christiansen H; Bremer M
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1523-9. PubMed ID: 22526164
[TBL] [Abstract][Full Text] [Related]
12. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
[TBL] [Abstract][Full Text] [Related]
14. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
[TBL] [Abstract][Full Text] [Related]
15. Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
Kübler J; Wester-Ebbinghaus M; Wenz F; Stieler F; Bathen B; Mai SK; Wolff R; Hänggi D; Blanck O; Giordano FA
J Neurosurg Sci; 2024 Feb; 68(1):22-30. PubMed ID: 32031357
[TBL] [Abstract][Full Text] [Related]
16. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
17. Salvage Leksell Stereotactic Radiosurgery for Malignant Gliomas.
Niranjan A; Kano H; Monaco Iii EA; Lunsford LD
Prog Neurol Surg; 2019; 34():191-199. PubMed ID: 31096255
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
[TBL] [Abstract][Full Text] [Related]
19. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
J Neurooncol; 2007 Feb; 81(3):287-94. PubMed ID: 17031558
[TBL] [Abstract][Full Text] [Related]
20. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]